Health Canada to review Medicago Phase 3 COVID-19 vaccine trials

As Canada’s COVID-19 immunization campaign accelerates, one of the country’s few homegrown vaccine candidates is moving ever closer to approval.

Quebec City-based Medicago announced last week that Health Canada has “received for review the first portion of Medicago's plant-derived COVID-19 vaccine candidate rolling submission.”